Neurocrine Biosciences, Inc. ( NASDAQ: NBIX) TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit September 17, 2025 12:40 PM EDT ...

Good morning, ladies and gentlemen, and welcome to aTyr Pharma conference call to review the top line results for the Phase III EFZO-FIT study of efzofitimod in pulmonary sarcoidosis. [Operator ...

In The Lancet Diabetes & Endocrinology, the STEP-UP T2D and STEP-UP trial groups present new findings on the efficacy and safety of higher-dose semaglutide (7·2 mg once weekly) in individuals with ...

Discover how mindful cannabis inhalation transforms smoking into a calming ritual of awareness, gratitude, and balance for ...

This article examines a holistic approach to youth mental health care and discusses the concept of ‘deprescribing’ as a systematic method for assessing the necessity and risks associated with the cont ...

The sleep study market is one of the most rapidly expanding sectors in the healthcare industry. As mentioned earlier, the ...

DelveInsight's GLP-1 Agonists Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...

This article explores advanced oligonucleotide analysis techniques, including chromatography methods for therapeutic RNA, ...

Language-guided image editing has achieved great success recently. In this paper, for the first time, we investigate exemplar-guided image editing for more precise control. We achieve this goal by ...

[25 July 2025 Editor's note: at its July meeting, the EMA's CHMP committee reversed its original negative opinion, and now recommends that the EMA grant a marketing authorization for Kisunla/donanemab ...